APA citiranje

Crossman, D., & Rothman, A. M. K. (2018). Interleukin-1 beta inhibition with canakinumab and reducing lung cancer—subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS). J Thorac Dis.

Citação norma Chicago

Crossman, David, and Alexander M. K. Rothman. "Interleukin-1 Beta Inhibition With Canakinumab and Reducing Lung Cancer—subset Analysis of the Canakinumab Anti-inflammatory Thrombosis Outcome Study Trial (CANTOS)." J Thorac Dis 2018.

MLA citiranje

Crossman, David, and Alexander M. K. Rothman. "Interleukin-1 Beta Inhibition With Canakinumab and Reducing Lung Cancer—subset Analysis of the Canakinumab Anti-inflammatory Thrombosis Outcome Study Trial (CANTOS)." J Thorac Dis 2018.